Skip to main content

REME-D

REME-D

Type

startup

Founded

2023

Funding captured

$2.0m

Deals captured

5

About REME-D

Reme-D develops and manufactures molecular diagnostic tests and portable diagnostic equipment for clinical laboratories, hospitals and research institutes. The company produces temperature‑resilient molecular assays for infectious diseases such as tuberculosis, HIV, hepatitis and HPV, designs compact battery‑operated diagnostic devices, and operates local manufacturing and commercialization from Cairo to supply tests across underserved markets in Africa and the broader MEA region. Its product portfolio includes dozens of in-house tests and temperature‑stable formats intended to reduce cold‑chain dependence and simplify laboratory workflows in low‑resource settings.

REME-D funding captured (5)

Deal typeStageDateAmountInvestors
EquityUnspecifiedUNDISCLOSEDundisclosedA15A15
************************************************undisclosed****************
************************************************$1.5m****************
************************************************$500.0k****************
************************************************$10.0k****************